Del Global Technologies Corp. (OTCBB: DGTC) (“Del Global” or “the Company”) today announced that Del Medical Systems Group has signed a two year supply agreement with Pinnacle Management Group for its DCChoice product line. Pinnacle is a chiropractic management group based in Tulsa, Oklahoma. With over one-thousand affiliate members in its network, Pinnacle is considered to be one of the premier practice management groups for chiropractors worldwide.

With an emphasis on maximizing practice revenues, Pinnacle carefully selects vendors, such as Del Medical, that will deliver on that promise to their member network. Del Medical™s Universal brand DCChoice provides expediency and flexibility for a small or start-up chiropractor™s office, resulting in lower overhead costs for the practitioner.

Joseph Flies, Vice President of Operations for the Del Medical Systems Group said, DCChoice allows doctors to see more patients in less time because of Del Medical™s advanced digital radiography technology. Pinnacle members are clearly excited by this product and we™re already seeing orders for the DCChoice and have several installations underway.

DC Choice by Universal combines simple operation with a sophisticated, cost effective direct digital chiropractic x-ray system that delivers high quality digital images. Anatomically Programmed Radiography (APR) techniques increase diagnostic and operator efficiencies and expedite throughput.


Del Global Technologies Corp. is primarily engaged in the design, manufacture and marketing of high performance diagnostic imaging systems for medical, dental and veterinary applications through the Del Medical Systems Group. Through its U.S. based Del Medical Imaging Corp. and Milan, Italy based Villa Sistemi Medicali S.p.A. subsidiaries, the Company offers a broad portfolio of general radiographic, radiographic/fluoroscopic, portable x-ray and digital radiographic systems to the global marketplace. Through its RFI subsidiary, Del Global manufactures proprietary high-voltage power conversion subsystems including electronic filters, high voltage capacitors, pulse modulators, transformers and reactors, and a variety of other products designed for industrial, medical, military and other commercial applications. The company™s web site is

Statements about future results made in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and the current economic environment. Del Global cautions that these statements are not guarantees of future performance. These statements involve a number of risks and uncertainties that are difficult to predict, including, but not limited to: the ability of Del Global to introduce products as scheduled; obtaining necessary product certification; implement its business plan; retention of management; changing industry and competitive conditions; obtaining anticipated operating efficiencies; securing necessary capital facilities; favorable determinations in various legal matters; market and operating risks from foreign currency exchange exposures; and favorable general economic conditions. Actual results could differ materially from those expressed or implied in the forward-looking statements. Important assumptions and other important factors that could cause actual results to differ materially from those in the forward-looking statements are specified in the Company’s filings with the Securities and Exchange Commission.

James A. Risher
Chief Executive Officer
(847) 288-7065
Mark A. Zorko
Chief Financial Officer
(847) 288-7003
Ethan Guttenplan
Account Executive
(212) 836-9605
Devin Sullivan
Senior Vice President
(212) 836-9608